Jonathan Javitt
-
NRx in Radnor Now Seeks Patent for COVID Drug Zyesami, Sees Other Uses
NRx Pharmaceuticals has now added a patent application to its paperwork for the COVID-19 therapy drug Zyesami, writes John George for Philadelphia Business Journal. Earlier…
-
NRx in Radnor Asks Again for Approval to Use Its COVID-19 Drug, Zyesami
NRx Pharmaceuticals out of Radnor has once again filed an application with the Food and Drug Administration for emergency use of its experimental COVID-19 drug…
-
Promising Results From COVID Drug Pushes Up Radnor Pharm’s Stock
Patients treated with an NRx Pharmaceuitcals drug candidate targeting COVID-19 showed “substantial improvement,” an analysis shows. The news caused the Radnor company’s stock to…
-
NeuroX in Radnor Tests Older Drug That Could Prevent COVID-19 Respiratory Failure
NeuroRX in Radnor and Wilmington is revitalizing a drug shelved 20 years ago that now shows promise in preventing respiratory failure for patients with COVID-19,…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
